Reteplase clinical trials
Also written CUSA-081.
How each study uses reteplase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the reteplase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Oct 1996 · Retavase · BLA 103786 (FDA, Purple Book)
- European Union
- 29 Aug 1996 · Rapilysin · EMEA/H/C/000105 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 4
Chiesi Farmaceutici S.p.A. (2) · Angde Biotech Pharmaceutical Co., Ltd. (1) · The University of Texas Health Science Center, Houston (1) · Yongjun Wang (1) · Ge Junbo (1) · Zeenat Qureshi Stroke Institute (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Thrombolytics source
Studies
Open first, then newest update. How each study uses reteplase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular EventsRecruitingPhase 3Yongjun WangNCT07748039Written as Reteplase 10 Units (U) plus a second dose of reteplase 10 U
- Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) FunctionalityTerminatedPhase 3Chiesi Farmaceutici S.p.A.NCT03594175Written as CUSA-081
- Endovascular Stroke Treatment And Reteplase ProtocolWithdrawnPhase 2Zeenat Qureshi Stroke InstituteNCT05900674Written as Reteplase Injection
- A Study of r-PA Treating Patients With Acute Ischemic Stroke(RAISE)CompletedPhase 3Angde Biotech Pharmaceutical Co., Ltd.NCT05295173Written as Injection of recombinant human tissue plasminogen kinase derivatives
- Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary InterventionTerminatedPhase 3Ge JunboNCT04571580Written as Reteplase Injection 9mg
- Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery RevascularizationCompletedPhase 4The University of Texas Health Science Center, HoustonNCT00178620Written as Reteplase 10 Units (U) plus a second dose of reteplase 10 U
- Efficacy and Safety of CUSA-081 in the Restoration of Dysfunctional Central Venous Access Device (CVAD) FunctionalityWithdrawnPhase 3Chiesi Farmaceutici S.p.A.NCT03992443Written as CUSA-081
What changed recently
From the registry's own updates since Oct 20, 2026.
Started recruiting1
Codes
What other systems call reteplase · ClinicalTrials.gg INT003791
- MeSH (NLM) C087896reteplaseConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) DQA630RIE9RETEPLASEConfirmed FDA, NLM, Wikidata
- RxNorm 76895Confirmed FDA, Wikidata
- Wikidata Q3933703reteplaseConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C90972ReteplaseOne source FDA
- DrugBank DB00015One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C087896 | reteplase | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | DQA630RIE9 | RETEPLASE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 76895 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3933703 | reteplase | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C90972 | Reteplase | One source FDA |
| DrugBank | DB00015 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.